These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12374046)

  • 21. Treatment of severe atopic dermatitis in childhood with cyclosporin.
    Zaki I; Emerson R; Allen BR
    Br J Dermatol; 1996 Sep; 135 Suppl 48():21-4. PubMed ID: 8881900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pseudotumor cerebri associated with cyclosporine use in severe atopic dermatitis.
    Blasco Morente G; Tercedor Sánchez J; Garrido Colmenero C; Martínez García E; Molina-Carballo A
    Pediatr Dermatol; 2015; 32(2):237-9. PubMed ID: 24330027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral Cyclosporine Weekend Therapy: A New Maintenance Therapeutic Option in Patients with Severe Atopic Dermatitis.
    Garrido Colmenero C; Blasco Morente G; Tercedor Sánchez J
    Pediatr Dermatol; 2015; 32(4):551-2. PubMed ID: 25939958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Topical immunomodulators, such as tacrolimus and pimecrolimus, in the treatment of atopic dermatitis].
    de Bruin-Weller MS; Bruijnzeel-Koomen CA
    Ned Tijdschr Geneeskd; 2005 May; 149(20):1096-100. PubMed ID: 15932135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cyclosporin in atopic dermatitis].
    Pacor ML; Biasi D; Di Lorenzo G; Carletto A; Corrocher R
    Recenti Prog Med; 2001 Jun; 92(6):390-1. PubMed ID: 11433717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The efficacy, tolerability and safety of a new oral formulation of Sandimmun--Sandimmun Neoral in severe refractory atopic dermatitis.
    Atakan N; Erdem C
    J Eur Acad Dermatol Venereol; 1998 Nov; 11(3):240-6. PubMed ID: 9883436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclosporin in the treatment of severe atopic dermatitis: a retrospective study.
    Lee SS; Tan AW; Giam YC
    Ann Acad Med Singap; 2004 May; 33(3):311-3. PubMed ID: 15175770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclosporin A reduces CD4(+)CD25(+) regulatory T-cell numbers in patients with atopic dermatitis.
    Hijnen D; Haeck I; van Kraats AA; Nijhuis E; de Bruin-Weller MS; Bruijnzeel-Koomen CA; Knol EF
    J Allergy Clin Immunol; 2009 Oct; 124(4):856-8. PubMed ID: 19767068
    [No Abstract]   [Full Text] [Related]  

  • 29. The immunomodulatory effect of topical cyclosporin A in atopic keratoconjunctivitis.
    Hingorani M; Calder VL; Buckley RJ; Lightman S
    Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):392-9. PubMed ID: 9950598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Risks of cyclosporine therapy in paediatric age].
    Antunes J; Gouveia C; Brito MJ
    Acta Med Port; 2010; 23(5):915-20. PubMed ID: 21144334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Soluble E-selectin correlates with disease activity in cyclosporin A-treated patients with atopic dermatitis.
    Kägi MK; Joller-Jemelka H; Wüthrich B
    Allergy; 1999 Jan; 54(1):57-63. PubMed ID: 10195358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-dose, but not high-dose, cyclosporin A promotes regulatory T-cell induction, expansion, or both.
    Baumgrass R; Brandt C; Wegner F; Abdollahnia M; Worm M
    J Allergy Clin Immunol; 2010 Jul; 126(1):183-4; author reply 184. PubMed ID: 20542321
    [No Abstract]   [Full Text] [Related]  

  • 33. A Monocentric Retrospective Cohort of Patients with Severe Atopic Dermatitis Treated with Cyclosporine A in Daily Practice.
    Daguzé J; Aubert H; Bernier C; Gaultier A; Nguyen JM; Stalder JF; Barbarot S
    Acta Derm Venereol; 2017 Aug; 97(8):955-956. PubMed ID: 28448098
    [No Abstract]   [Full Text] [Related]  

  • 34. Keratoplasty postoperative treatment update.
    Shimmura-Tomita M; Shimmura S; Satake Y; Shimazaki-Den S; Omoto M; Tsubota K; Shimazaki J
    Cornea; 2013 Nov; 32 Suppl 1():S60-4. PubMed ID: 24104936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting keratinocyte apoptosis in the treatment of atopic dermatitis and allergic contact dermatitis.
    Trautmann A; Akdis M; Schmid-Grendelmeier P; Disch R; Bröcker EB; Blaser K; Akdis CA
    J Allergy Clin Immunol; 2001 Nov; 108(5):839-46. PubMed ID: 11692113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Update on systemic therapies for atopic dermatitis.
    Denby KS; Beck LA
    Curr Opin Allergy Clin Immunol; 2012 Aug; 12(4):421-6. PubMed ID: 22622476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topical tacrolimus in the management of atopic dermatitis in Japan.
    Furue M; Uchi H; Moroi Y; Ogawa S; Nakahara T; Urabe K
    Dermatol Ther; 2006; 19(2):118-26. PubMed ID: 16669995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Value of protecting mitochondrial functions during treatment with cyclosporin A].
    Simon N; Albengres E; Barré J; Jolliet P; Urien S; Settaf A; Tillement JP
    Therapie; 1997; 52(2):151-4. PubMed ID: 9231511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclosporin A (CyA) reduces sCD30 serum levels in atopic dermatitis: a possible new immune intervention.
    Bottari V; Frezzolini A; Ruffelli M; Puddu P; Fontana L; De Pità O
    Allergy; 1999 May; 54(5):507-10. PubMed ID: 10380784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Refractory atopic dermatitis treated with low dose cyclosporin.
    Yu FC; Gibbon GW; Klaustermeyer WB
    Ann Allergy Asthma Immunol; 2002 Aug; 89(2):127-31. PubMed ID: 12197567
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.